Hearing tech startup Legato emerges from stealth with $12M and a peek at its AI hearing glasses

Legato, a San Francisco hearing tech startup founded in late 2024 by two Bose veterans, emerged from stealth today with $12 million in seed funding and a working prototype of AI-powered eyewear called Legato Frames — glasses that treat hearing loss the way corrective lenses treat blurry vision. The company says it will distribute through eye-care providers, not audiologists, and targets a fall 2026 launch at a price point well below traditional hearing aids.

What's Converging

The hearing-loss market has been accumulating pressure for years without a clean release valve. An estimated 50 million American adults have some degree of hearing loss, and roughly 80% of them don't seek treatment — a gap driven not by ignorance of the problem but by cost, comfort, and the social stigma of wearing a visible medical device. That untreated majority is the market Legato is positioning itself for, and it's not alone in noticing the opportunity.

Apple's FDA-cleared hearing feature for AirPods, which arrived in late 2024, showed that attaching hearing assistance to a form factor people already wear is a viable route around stigma. EssilorLuxottica — the optical giant behind Ray-Ban — has been selling its own Nuance Audio Glasses in that same direction. Startup Fortune notes these are the products Legato is implicitly competing against, which puts the new entrant in a space that has already attracted major incumbents. The question Legato is betting on isn't whether the market exists, but whether an AI-native architecture can outperform hardware that was designed around older signal-processing assumptions.

That bet is specific: directional microphones, the standard approach in hearing aids, try to solve the noisy-restaurant problem by favoring sounds coming from one direction. In practice, they amplify everything in front of the wearer, which in a crowded environment means amplifying competing conversations, music, and kitchen noise alongside the one voice the person is trying to hear. The cognitive load of separating signal from noise still falls on the listener. Legato's argument is that a trained classifier — software that has learned to distinguish speech from background sound — should handle that separation before it reaches the ear, not after.

The Specific Development

Legato's co-founders are Mehul Trivedi and Steve Romine, and their résumés are the clearest signal of what this company is trying to build. Trivedi created Bose Frames — the audio sunglasses that quietly built a small market for lifestyle-focused hearing-adjacent wearables — then moved to EssilorLuxottica, where he led smart eyewear development and worked directly on the Meta Ray-Bans. Romine ran Bose's hearing aids division before serving as COO of Audicus, an online hearing care company. Multiple reports confirm that the two reconnected in late 2024 after Trivedi spent time exploring the overlap between hearing tech and smart eyewear, and decided to build something together.

The $12 million round was led by Neotribe Ventures, with participation from Listen and Village Global, according to TechCrunch's exclusive. One corroborating source, AIBeat.dev, lists a different set of investors entirely — Andreessen Horowitz, a16z Bio + Health, and Khosla Ventures — along with technical specifications (a 12-layer convolutional neural network running in under 15 milliseconds, trained on 200,000 hours of multi-environment audio) that don't appear in the TechCrunch account or any other source. Given the low confidence of that report and the fact that TechCrunch had the exclusive, those investor names and technical specs should be treated as unverified until Legato or the investors confirm them.

What the primary reporting does confirm: the Legato Frames embed the company's patented hearing-assistance technology into the arms of the glasses, with an open-ear dual-speaker system that directs sound toward the wearer while canceling outward-escaping audio by 99% within a few inches. There are no controls — no app configuration, no fiddling — and the device is designed to run through a 16-hour day without demanding attention from the user. The AI does the voice-separation work in real time, automatically. Trivedi's stated goal is to make hearing care feel as unremarkable as wearing corrective lenses: something you address once, then forget about.

Crucially, Legato is going to market through eye-care providers rather than audiologists or hearing clinics. That's a deliberate choice. Buying glasses from an optometrist doesn't carry the same social freight as walking into a hearing clinic, and the company is exploring whether the Frames can qualify for vision insurance coverage — a pathway that would substantially change the effective price for millions of people. The startup is targeting mild-to-moderate hearing loss, which represents the largest underserved segment: people who notice the problem in noisy environments but haven't yet crossed the threshold into the formal medical channel.

Our read is that the distribution strategy is as important as the hardware. You can build a technically superior product and still lose if it sits behind a specialist referral network that 80% of potential users are actively avoiding. Routing through eye-care providers is a real attempt to solve the access problem, not just the engineering problem.

What's Likely Next

The immediate question is pricing. Legato's positioning relative to Apple's AirPods hearing mode and EssilorLuxottica's Nuance Glasses will depend heavily on where the Frames land in cost — the company has described it as "a fraction of traditional hearing aids," but traditional hearing aids range from a few hundred to several thousand dollars depending on the tier. A fall 2026 launch gives roughly 60 to 90 days for retail pricing and insurance eligibility details to surface. Those numbers will determine whether the eye-care distribution strategy can actually convert the 80% who aren't currently being reached, or whether the product ends up serving the same relatively affluent early-adopter segment that already buys premium audio eyewear.

The second open question is regulatory. Apple's AirPods hearing feature cleared the FDA as an over-the-counter hearing aid, which required meeting specific performance standards. Whether Legato Frames pursues OTC clearance, Class II medical device status, or sidesteps the medical designation entirely will shape what claims the company can make, which insurance codes apply, and how quickly it can expand beyond an initial network of eye-care partners. The company hasn't disclosed its regulatory plan publicly, and that gap is worth watching.

Sources